ConductScience.org, home

Paper31410844

Unmet Acute Treatment Needs From the 2017 Migraine in America Symptoms and Treatment Study.

Lipton RB and 7 others. Headache, 2019. Cited by 63 papers, by iCite.

Cite this record

ConductScience Library. Unmet Acute Treatment Needs From the 2017 Migraine in America Symptoms and Treatment Study. Papers, record 31410844. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31410844

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Unmet Acute Treatment Needs From the 2017 Migraine in America Symptoms and Treatment Study.
PubMed
Journal
Headache
PubMed
Year
2019
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
63
iCite
Relative citation ratio, by iCite
4.39
iCite
Revised in PubMed
2020-07-13
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lipton RBRichard B
2Munjal SSagar
3Buse DCDawn C
4Alam AAftab
5Fanning KMKristina M
6Reed MLMichael L
7Schwedt TJTodd J
8Dodick DWDavid W

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AnalgesicsMajor topic
Migraine DisordersMajor topic
Needs AssessmentMajor topic
Treatment OutcomeMajor topic
Adult
Cross-Sectional Studies
Female
Humans
Longitudinal Studies
Male
Middle Aged
Surveys and Questionnaires
United States

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Dr. Reddy's Laboratories group of companiesInternationalPubMed

Source PubMed

Download CSV of grants

References38

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129368949Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition.Cephalalgia2018https://conductscience.org/library/papers/29368949PubMed
223879870Examination of unmet treatment needs among persons with episodic migraine: results of the American Migraine Prevalence and Prevention (AMPP) Study.Headache2013https://conductscience.org/library/papers/23879870PubMed
325246519Adverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: systematic review of observational studies.Cephalalgia2015https://conductscience.org/library/papers/25246519PubMed
421457175Emergency department consultations for patients with neurological emergencies.Eur J Neurol2011https://conductscience.org/library/papers/21457175PubMed
511554951Migraine diagnosis and treatment: results from the American Migraine Study II.Headache2001https://conductscience.org/library/papers/11554951PubMed
612656703Health care utilization in patients with migraine: demographics and patterns of care in the ambulatory setting.Headache2003https://conductscience.org/library/papers/12656703PubMed
721187794Assessing the impact of migraine onset on work productivity.J Occup Environ Med2011https://conductscience.org/library/papers/21187794PubMed
81727198Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors.JAMA1992https://conductscience.org/library/papers/1727198PubMed
929445880The headache under-response to treatment (HURT) questionnaire, an outcome measure to guide follow-up in primary care: development, psychometric evaluation and assessment of utility.J Headache Pain2018https://conductscience.org/library/papers/29445880PubMed
1015531016Priorities for triptan treatment attributes and the implications for selecting an oral triptan for acute migraine: a study of US primary care physicians (the TRIPSTAR Project).Clin Ther2004https://conductscience.org/library/papers/15531016PubMed
1125881676Acute treatment optimization in episodic and chronic migraine: results of the American Migraine Prevalence and Prevention (AMPP) Study.Headache2015https://conductscience.org/library/papers/25881676PubMed
1219239676Validity and reliability of the Migraine-Treatment Optimization Questionnaire.Cephalalgia2009https://conductscience.org/library/papers/19239676PubMed
1323808937Effects of switching acute treatment on disability in migraine patients using triptans.Headache2013https://conductscience.org/library/papers/23808937PubMed
1430341895Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender Differences.Headache2018https://conductscience.org/library/papers/30341895PubMed
158857711Classification of daily and near-daily headaches: field trial of revised IHS criteria.Neurology1996https://conductscience.org/library/papers/8857711PubMed
1611554952Prevalence and burden of migraine in the United States: data from the American Migraine Study II.Headache2001https://conductscience.org/library/papers/11554952PubMed
1715265257Identifying patients who require a change in their current acute migraine treatment: the Migraine Assessment of Current Therapy (Migraine-ACT) questionnaire.Curr Med Res Opin2004https://conductscience.org/library/papers/15265257PubMed
1815846257
Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE).
Am Heart J2005https://conductscience.org/library/papers/15846257PubMed
1924932784What do patients consider to be the most important outcomes for effectiveness studies on migraine treatment? Results of a Delphi study.PLoS One2014https://conductscience.org/library/papers/24932784PubMed
204650929Indices of relative weight and obesity.J Chronic Dis1972https://conductscience.org/library/papers/4650929PubMed

See all 38 referencesDownload CSV of references

Cited by39

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 63 citations.

PMIDTitleJournalYearIn PapersSource
42639778Efficacy and safety of Dingluo nasal drops for the acute treatment of migraine: a pilot randomized trial.J Tradit Chin Med2026https://conductscience.org/library/papers/42639778PubMed
42143245Rimegepant for the acute treatment of migraine: a systematic review and meta-analysis.J Headache Pain2026https://conductscience.org/library/papers/42143245PubMed
41794348Intranasal hybrid nanoparticles encapsulating rizatriptan enhance antimigraine efficacy in an optogenetic spreading depression model.Int J Pharm2026https://conductscience.org/library/papers/41794348PubMed
41721442Unmet treatment needs in migraine: Results of the OVERCOME (US) study.Headache2026https://conductscience.org/library/papers/41721442PubMed
41300216Green Light and Transcranial Direct Current Stimulation in Migraine Patients: A Preliminary Randomized Control Trial.Brain Sci2025https://conductscience.org/library/papers/41300216PubMed
41186275Study participant impression of use and satisfaction with STS101 (dihydroergotamine nasal powder): Results from the open-label ASCEND acute migraine study.Headache2026https://conductscience.org/library/papers/41186275PubMed
41068578Adherence status and influencing factors of acute and preventive pharmacotherapy among migraine patients in China.J Headache Pain2025https://conductscience.org/library/papers/41068578PubMed
39030417A Retrospective Analysis of Disease Epidemiology, Comorbidity Burden, Treatment Patterns, and Healthcare Resource Utilization of Migraine in the United Arab Emirates.Pain Ther2024https://conductscience.org/library/papers/39030417PubMed
38865075Light Therapy in Chronic Migraine.Curr Pain Headache Rep2024https://conductscience.org/library/papers/38865075PubMed
38822165Intervening in the Premonitory Phase to Prevent Migraine: Prospects for Pharmacotherapy.CNS Drugs2024https://conductscience.org/library/papers/38822165PubMed
38370478Real-world observations and impacts of Chinese herbal medicine for migraine: results of a registry-based cohort study.Front Pharmacol2024https://conductscience.org/library/papers/38370478PubMed
38349136Update on gepants for the treatment of chronic migraine.J Chin Med Assoc2024https://conductscience.org/library/papers/38349136PubMed
38289612Impact of Neurolens Use on the Quality of Life in Individuals With Headaches: A Randomized Double-Masked, Cross-Over Clinical Trial.Transl Vis Sci Technol2024https://conductscience.org/library/papers/38289612PubMed
36944864Real-World Analysis of Clinical Characteristics, Treatment Patterns, and Patient-Reported Outcomes of Insufficient Responders and Responders to Prescribed Acute Migraine Treatment in China.Pain Ther2023https://conductscience.org/library/papers/36944864PubMed
36438031Chinese herbal medicine for migraine management: A hospital-based retrospective analysis of electronic medical records.Front Med (Lausanne)2022https://conductscience.org/library/papers/36438031PubMed
36239038Zavegepant nasal spray for the acute treatment of migraine: A Phase 2/3 double-blind, randomized, placebo-controlled, dose-ranging trial.Headache2022https://conductscience.org/library/papers/36239038PubMed
36068494Quantity changes in acute headache medication use among patients with chronic migraine treated with eptinezumab: subanalysis of the PROMISE-2 study.J Headache Pain2022https://conductscience.org/library/papers/36068494PubMed
35859654Delta opioid receptors in Nav1.8 expressing peripheral neurons partially regulate the effect of delta agonist in models of migraine and opioid-induced hyperalgesia.Neurobiol Pain2022https://conductscience.org/library/papers/35859654PubMed
35468729
Functionality, satisfaction, and global impression of change with ubrogepant for the acute treatment of migraine in triptan insufficient responders: a post hoc analysis of the ACHIEVE I and ACHIEVE II randomized trials.
J Headache Pain2022https://conductscience.org/library/papers/35468729PubMed
35343590Real-world assessment of the relationship between migraine-related disability and healthcare costs in the United States.Headache2022https://conductscience.org/library/papers/35343590PubMed

See all 39 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/31410844

GET https://conductscience.org/api/papers/v1/31410844/references?page=2